Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact? (Q44780567)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2004
edit
Language Label Description Also known as
English
Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?
scientific article published in March 2004

    Statements

    Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact? (English)
    1 March 2004
    759-761

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit